Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.44 | €10.56 | 137.922% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.22 | €11.00 | 52.397% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.92 | €11.05 | 181.847% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €15.80 | €12.06 | -23.646% |
| Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.22 | €12.18 | 448.577% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 0 | 1 | €4.78 | €12.80 | 167.814% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
| MacroGenics Inc. | 14 | 1 | 5 | 1 | €3.07 | €14.25 | 363.696% |
| Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.78 | €15.58 | -1.235% |
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.70 | €17.21 | 47.116% |
| Kezar Life Sciences | 5 | 0 | 1 | 0 | €0.75 | €18.56 | 2391.812% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.90 | €20.43 | 71.702% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €10.18 | €22.78 | 123.726% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.80 | €24.13 | 63.117% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €25.14 | 14.291% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 1 | 0 | €11.90 | €25.58 | 114.941% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €9.96 | €26.95 | 170.688% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.42 | €28.06 | 81.953% |